Latest action: Referred to the House Committee on Energy and Commerce.
Bill is filed in its originating chamber and assigned a number.
Filed in the House.
Next: In Committee
Members of the committee(s) the bill was referred to
Allows Americans to import cheaper prescription drugs from other countries.
The problem
Prescription drug prices in the U.S. are higher than in other developed nations. Many Americans struggle to afford medications they need.
The proposal
Permits licensed pharmacies and wholesalers to import FDA-approved drugs from Canada and other countries where prices are lower.
The impact
Patients may pay less for medicines. Pharmaceutical companies could see lower U.S. sales. Drug supply chains may become more complex.
Americans could purchase the same medications at significantly reduced prices by importing from countries with price controls. This helps patients afford necessary treatments and reduces financial hardship.
International drug importation introduces price competition, which may force domestic pharmaceutical companies to lower prices to remain competitive. This benefits consumers across the board.
Lower prescription drug costs decrease total healthcare expenses for individuals, insurance companies, and government programs like Medicare and Medicaid.
The bill only allows import of drugs already approved by the FDA, meaning safety standards remain unchanged from domestically purchased versions.
Importing drugs creates risks of counterfeit or contaminated medications entering the supply chain. Oversight of foreign manufacturing may be more difficult than domestic monitoring.
Lower profits from drug sales may discourage research into new medications. Companies might invest less in developing treatments for rare or serious diseases.
Other countries may restrict exports to protect their own drug supplies. Large-scale importation could reduce medication availability in those nations or create shortages.
Domestic pharmaceutical manufacturers and workers could lose jobs if companies reduce U.S. production due to lower sales from imported competition.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.